Abstract
As artificial intelligence (AI) has been highly advancing in the last decade, machine learning (ML) enabled medical devices are increasingly used in healthcare. In this article, we performed comprehensive analysis of FDA approved Artificial Intelligence and Machine Learning (AI/ML)- Enabled Medical Devices and offer an in-depth analysis of clearance pathways, approval timeline, regulation type, medical specialty, decision type, recall history etc. We found a significant surge in approvals since 2018, with clear dominance of radiology specialty in the application of machine learning tools, attributed to the abundant data from routine clinical data. The study also reveals a reliance on the 510(k)-clearance pathway, emphasizing its basis on substantial equivalence and often bypassing the need for new clinical trials. Also, it notes an underrepresentation of pediatric- focused devices and trials, suggesting an opportunity for expansion in this demographic. Moreover, the geographical limitation of clinical trials, primarily within the United States, points to a need for more globally inclusive trails to encompass diverse patient demographics. This analysis not only maps the current landscape of AI/ML-Enabled Medical Devices but also pinpoints trends, potential gaps, and areas for future exploration, clinical trial practices, and regulatory approaches.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing Interest Statement The authors have declared no competing interest.
Section on Abstract, Introduction, Method, Result, Discussion and Conclusions were updated after adding new data fro 2023; Simialrly, all figures were revised to incorportae new data as well as new images were added for additional data; author information was updated to add one new author who worked on the new data used in te updated analysis; Supplemental files updated.
Data Availability
All data produced are available online at FDA webpage.
